← Leaderboards
Konstantine Halkidis
University Of Kansas Medical Center
$660,960
Attributed
$660,960
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $165.2K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$660,960 · 1
By mechanism
K08$660,960 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- X. Long Zheng$11,062,949
- Nathan Bahr$5,885,913
Others in their field
Other Rising Stars on “Disease Management”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Jessica Holden · Technical Resources International, Inc.$37,843,443
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Brian Zavertnik · Palantir Technologies, Inc.$22,886,494
- Calvin Proffitt · Leidos Biomedical Research, Inc.$19,442,847
Research focus
Disease ManagementAdvisory CommitteesAffectAgreementAffinityAreaAgglutinationAutoimmuneBindingBinding SitesBlood PlateletsAntibodiesCareerCareer DevelopmentAutoantibodiesCleavage FactorClinicClinical ManagementCoupledDeuteriumDevelopment PlansDiagnosticDiagnostic TestsDisintegrins
Grant awards (4)
Exploring the mechanisms of action of anti-ADAMTS 13 antibodies in immune thrombotic thrombocytopenic purpura$165,240
K08 · FY2025 · HL · contact PI
Exploring the mechanisms of action of anti-ADAMTS 13 antibodies in immune thrombotic thrombocytopenic purpura$165,240
K08 · FY2024 · HL · contact PI
Exploring the mechanisms of action of anti-ADAMTS 13 antibodies in immune thrombotic thrombocytopenic purpura$165,240
K08 · FY2023 · HL · contact PI
Exploring the mechanisms of action of anti-ADAMTS 13 antibodies in immune thrombotic thrombocytopenic purpura$165,240
K08 · FY2022 · HL · contact PI